The rising power of limited leading drug companies is raising serious concerns worldwide. This pattern click here towards domination often results to higher drug prices, reduced innovation, and challenges in accessing critical therapies for people throughout the planet. Researchers believe that stronger regulation is required to resolve these probl

India's pharmaceutical landscape presents a complex picture, largely shaped by the considerable influence of a few dominant players. While the sector is often lauded for its generic drug manufacturing capabilities, a closer examination reveals a degree of sector concentration that warrants scrutiny. These incumbent companies, including organization